HomeOpen Access NewsEuropean Union

European Union

Record number of proposals for MSCA COFUND programme

The 2025 call for the Marie Skłodowska-Curie Actions (MSCA) COFUND scheme has closed with a record 136 proposals submitted, which is a significant increase from previous years.

Horizon Europe: EU research & innovation

Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, describes Horizon Europe and scaling up high-impact and breakthrough research & innovation.

EU allocates additional €500 million to COVAX facility

The European Union has allocated an additional €500 million to the COVAX facility, bringing its total contribution to €1 billion.

Commission launches “HERA Incubator” project to fight COVID mutations

The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.

COVID-19 and drugs in the European neighbourhood partnership countries

The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.

A post-Brexit economy: Where do we go next?

Institute of Economic Development Executive Director Nigel Wilcock and Director Paul Frainer discuss economic life in the UK after leaving the European Union.

European Commission presents Europe’s Beating Cancer Plan

The European Commission has announced its Europe's Beating Cancer Plan which sets out a new EU approach to cancer prevention, treatment and care.

European Commission pays out €14 billion under the SURE programme

The European Commission has allocated €14 billion to nine Member States under the Support to mitigate Unemployment Risks in an Emergency (SURE) programme.

Brexit briefing: Understanding new employment laws

Kathryn Barnes, Employment Counsel EMEA, Globalization Partners, discusses the changes to UK employment laws as a result of Brexit.

The EU authorises AstraZeneca COVID vaccine for use

European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.

Is this a vaccine war or the first post-Brexit war?

Right now, the rift between AstraZeneca and the European Commission continues to grow - but is it a vaccine war or the first post-Brexit war?

AstraZeneca CEO discusses the European Commission vaccine feud

AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.

European Commission approves second IPCEI on batteries

The European Commission has given the green light on the second Important Project of Common European Interest (IPCEI) in the field of batteries.

BlueInvest fund gives €45 million to food security projects

The BlueInvest fund today allocated the first of an available €75 million to two projects working against food insecurity - announcing the names at a BlueInvest Day event.

European Commission to create “transparency mechanism” for vaccine exports

In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.

European Commission launches new Green Consumption Pledge

The European Commission has launched its new Green Consumption Pledge, the first initiative delivered under the New Consumer Agenda.

European Commission will get 60% less AstraZeneca vaccines

EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders